Both these proteins showed a reverse longitudinal trend in followed up patients, and we noticed increased transferrin levels with reduced TfR levels in ATB patients completing 6 months of TB treatment compared to their drug-naïve status (Figure 6B). The gene discussed is TFRC; the disease is tuberculosis.